HIV-related haematological malignancies: a joint Series from The Lancet Haematology and The Lancet HIV

1 hr

Satish Gopal

Ariela Noy

Thomas S. Uldrick

Peter Hayward

title

Save

Comment

About this video

Since the earliest days of the HIV epidemic, haematological malignancies have been a defining feature of illness caused by the virus; individuals with HIV are living longer and contending with the challenges of treating cancer while on ART, now, work on haematological cancers is providing insights into how a cure for HIV might be achieved. Join Peter Hayward, Editor-in-Chief of The Lancet HIV, and the Series authors as they introduce and explore the findings from this new joint Series on HIV-related haematological malignancies from The Lancet Haematology and The Lancet HIV.

About the presenters

Satish Gopal

National Cancer Institute Center for Global Health, Rockville, MD, USA

Satish Gopal oversees the development of initiatives and collaborations with other National Cancer Institute (NCI) divisions, NCI-Designated Cancer Centers, and countries to support cancer research and cancer research networks, promote cancer control planning, and build capacity in low- and middle-income countries.

Ariela Noy

Memorial Sloan Kettering Cancer and Weill Medical College, New York, NY, USA

Ariela Noy, MD, is an Attending and Member of the Lymphoma Service in the Hematology Division at the Memorial Sloan-Kettering Cancer in New York. She has expertise in the treatment of a wide variety of hematological malignancies with particular emphasis on Hodgkin and non-Hodgkin lymphoma, CLL and AIDS related malignancies. Over two decades, she has been the principal investigator, co-PI or co-investigator on over 100 trials.

Thomas S. Uldrick

Fred Hutchinson Cancer Research Center, Seattle, WA, USA

Thomas S. Uldrick is a clinical investigator whose research focuses on viral and immune factors that contribute to cancer pathogenesis in the setting of HIV and cancer immunotherapy clinical trials in people with virus associated malignancies.

Peter Hayward

Editor-in-Chief, The Lancet HIV, London, UK

Peter Hayward was previously Deputy Editor of The Lancet Infectious Diseases from 2010 and helped to introduce original research and Fast Track peer review to that journal. He is the founding Editor of The Lancet HIV.